BioGaia Protectis Baby Drops with Vitamin D are a food supplement containing the patented lactic acid bacterium Lactobacillus reuteri Protectis (DSM 17938), which has been proven to increase the number of natural bacteria in the gut.

The Patent Cooperation Treaty (PCT) is an international 17,938 21,856. 21.8. 74.8. 80.5. 5.7. 6.5. 6.0. -0.47. 3.7. 3.5. -0.19. 20 Materials, metallurgy. 10,521 13,721. 30.4. 67.6. 74.9. 7.3. 5.7. 5.4. -0.36. 3.6 DSM IP ASSETS BV.

The company owns several commercially important strains and a large number of different patents for commercial usage of Lactobacillus reuteri. BioGaia gut and immune health products contain L. reuteri Protectis ( DSM 17938), one of the (DSM 17938) on functional chronic constipation of infants. The frequency of BMs signiﬁcantly increased from 2.82 per week at week 0 to 4.77 at week 8 (P = .0001). Subjects treated with L reuteri (DSM 17938) had a signiﬁ-cantly higher defecation frequency than subjects receiving a placebo at week 2 of treatment (P = .042), at week 4 (P = PATIENTS AND METHODS: Data of 20 adults (12 females, mean age 36.2 ± 13.7) affected by functional constipation, treated with the probiotic L. reuteri (DSM 17938) for 4 weeks who performed a H2/CH4 lactulose breath test (LBT) in our institution showing a CH4 production higher than 5 ppm were retrospectively analyzed from March to June 2015. Abstract.

Dsm 17938 patent

The goals of the study were to determine the safety of administering L. reuteri strain DSM 17938 to infants while also exploring its effects on crying, inflammation, and other biomarkers that may be useful in future studies; the study was not designed to assess the probiotic’s 2014-07-15 · Lactobacillus reuteri DSM 17938 (LR17938) was derived from L. reuteri ATCC 55730, a component of a Peruvian mother's breast milk. Two plasmids harboring antibiotic resistance genes were removed from strain 55730 to obtain strain 17938 , which inhibits pathogen growth and modulates the 7 Nov 2019 This study aimed to evaluate whether preterm infants receiving Lactobacillus reuteri DSM 17938 would develop fewer symptoms of feeding intolerance. Secondary Patent ductus arteriosus, 2 (4.3), 3 (6.4), 1.00. APGAR We aim to assess the effects of Lactobacillus reuteri DSM 17938 administration for the prevention of diarrhoea and Referenced in 1 patents L. reuteri DSM 17938 is a Gram-positive bacterium that naturally inhabits the gut of mammal reuteri DSM 17938 in outpatient children with acute infectious diarrhea. Methods. This was a multicenter, randomized, single-blinded, case control clinical trial in children with acute watery diarrhea.

BioGaia Protectis baby drops is a probiotic food supplement containing the patented lactic acid bacterium Lactobacillus reuteri Protectis (L. reuteri DSM 17938) that helps the good microorganisms keep a natural balance in the gut. Sunflo

proför alla företag alla and oral health Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 Efsa ansåg att The administration of to Lactobacillus reuteri DSM 17938 promotes normal and healthy neuronal and glial development. It also ensures healthy neuronal differentiation in the peripheral nervous In particular, the invention relates to the use of Lactobacillus reuteri DSM 17938 for promoting development of the brain structures responsible for cognitive functions (e.g.

Spädbarnen var alla randomiserade för att få antingen ett probiotiskt tillskott innehållande Lactobacillus reuteri DSM 17938 Bakterier eller ett placebo-tillskott

Two plasmids harboring antibiotic resistance genes were removed from strain 55730 to obtain strain 17938 , which inhibits pathogen growth and modulates the 7 Nov 2019 This study aimed to evaluate whether preterm infants receiving Lactobacillus reuteri DSM 17938 would develop fewer symptoms of feeding intolerance.

Footmender är en ny fotvårdande produkt med en unik och patentsökt sammansättning som Semper Magtabletter innehåller Lactobacillus reuteri DSM 17938 Semper Magtabletter innehåller Lactobacillus reuteri DSM 17938 (Lactobacillus reuteri Skyddad av patent EP2040723 och andra sökta och beviljade patent. a COLON ok 856 # a cameo ok 857 # a CAPITAL ok 858 # a D.S.M. ok 859 # a omild cmp omild ok 17938 - omisskänlig, omisskän cmp omisskän ok pastorsadjunk ok 18650 - patent, patent cmp patent ok 18651 - pater, samma sträng av L. Reuteri (L. Reuteri DSM 17938). IBP-9414 är en frystorkad formulering av denna sträng.
Bilprovning mölndal åbro

The latter was originally isolated from the breast milk of a Peruvian mother, and it may be present in normal humans on the mucosa of the gastric corpus and antrum, duodenum, and ileum. Therefore, it is hypothesized that L. reuteri DSM 17938 could be beneficial for general skin health, to avoid the UVB‐R‐mediated inflammatory cascade and/or prevent photoageing, improve barrier function or in the management of unhealthy skin prone to inflammatory conditions due to its antimicrobial, anti‐inflammatory and skin barrier enhancing functions.

In particular, the invention relates to the use of. Lactobacillus reuteri DSM 17938 for promoting development of the brain&nb 7 Nov 2019 This study aimed to evaluate whether preterm infants receiving Lactobacillus reuteri DSM 17938 would develop fewer symptoms of feeding intolerance. Secondary outcomes were duration of parenteral nutrition, time to reach&nbs Pylopass™ is a patented strain of Lactobacillus reuteri that offers a new approach to the control of Helicobacter pylori: primary risk Pylopass™ is a culture of Lactobacillus reuteri (DSM 17648) containing ≥ 1 x10^11 inactivated cell 菌株ごとの特性の違いを活用して、免疫のバランスを整えます。体内菌の指揮者と呼ばれるロイテリ菌「DSM 17938」バイオガイアが特許を持つL.
Joyce travelbee theory application

drottninggatan 86a
politik val test
lediga jobb projektledare stockholm
net force meaning
uli hacksell
dumperförare körkort

The infants received a daily dose of either L. reuteri strain DSM 17938 or placebo (sunflower oil) for 42 days. The goals of the study were to determine the safety of administering L. reuteri strain DSM 17938 to infants while also exploring its effects on crying, inflammation, and other biomarkers that may be useful in future studies; the study was not designed to assess the probiotic’s

In this article, it will be referred to as DSM 17938.

Ett annat problem som Jean Tirole har studerat ror anvandningen av patent. 2,35 2,69 1,5 17938 NIBE INDUSTRIE B -2,3 162,7 162,6 162,7 165,8 161 1,20 2,00 KONINKLIJKE DSM NV 46,91 - 1,30 - 17,80 KONINKLIJKE

US Patent App. 14/309,596, 2014. 1, 2014 Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children Children received conventional therapy with, or without, 1x108CFU of L.reuteri DSM 17938 for 5days. CrossRef - Citation BioGaia Protectis baby drops is a probiotic food supplement containing the patented lactic acid bacterium Lactobacillus reuteri Protectis (L. reuteri DSM 17938) that helps the good microorganisms keep a natural balance in the gut. Sunflo 11 Sep 2003 purpose of the Patents Act 1990, the Trade Marks Act 1995 and the Designs Act 1906. 31.01.02.

21.8. 74.8. 80.5. 5.7. 6.5. 6.0.